Lmst
Login

#immunotherapy

Robert Lufkin MDrobertlufkinmd
2026-02-22

16-Hour Fasting: A Game-Changer for Cancer Immunotherapy 🧬⏱️

New clinical data in Cell Metabolism (Feb 2026) reveals that strategic fasting is more than just a metabolic trend—it's a powerful tool in oncology.

The Key Findings: A 16-hour fasting window "reprograms" T cells, making them more resilient and aggressive against tumors.
Short-term fasting significantly enhances neoadjuvant immunothera... sciencedirect.com/science/arti

Scientific Frontlinesflorg
2026-02-17

Analysis of 51 undergoing reveals a significant correlation between gut composition and survival duration, identifying 11 specific bacterial types as predictive indicators of longevity.

sflorg.com/2026/02/vet02172601

Scientific Frontlinesflorg
2026-02-15

A shift in treatment strategy where is administered at earlier stages of the disease—specifically before or after surgery—rather than being reserved solely for advanced, inoperable cases.

sflorg.com/2026/02/imgy0215260

Scientific Frontlinesflorg
2026-02-14

An advanced form of in which Chimeric Antigen Receptor (CAR) T cells are genetically engineered to resist immunosuppressive signals found within solid tumors, enabling the immune system to effectively destroy cells that were previously resistant to treatment.

sflorg.com/2026/02/ongy0214260

Summarized Sciencesummarized
2026-02-14

🧬 Extracellular Vesicles — Jan 2026

• Inhalable and engineered EVs overcome immunotherapy resistance
• EV-derived miRNAs reprogram macrophage phenotypes in cancer
• Regenerative applications expand in cardiac, cartilage, and tendon repair

pir.sh/Wl4dn6Ad0G

Summarized Sciencesummarized
2026-02-12

🧬 Tumor Microenvironment — Jan 2026

• Engineered CAR-T and TAM targeting reshape local immunity
• Fibroblast checkpoints and macrophage signaling drive resistance
• DNA sensing and pyroptosis pathways amplify immunotherapy response
• Population-scale modeling refines immune stratification

pir.sh/9XygJPXd3w

Summarized Sciencesummarized
2026-02-12

🎗️ Melanoma — Recent Research

• Long-term survival improves with neoadjuvant checkpoint blockade
• Targeted therapy benefits linked to mutation burden
• CRISPR screens and toxicity insights refine immunotherapy strategy

pir.sh/rk915wQanp

Technische Universität Münchentu_muenchen@wisskomm.social
2026-02-11

Researchers, including Florian Bassermann, uncover and block the #protein mechanism that weakens treatment for multiple myeloma. In an initial study they succeeded in blocking it using an existing #cancerdrug: go.tum.de/307361

#oncology #immunotherapy

đź“·K. Czoppelt

Biostockbiostock
2026-02-11

Neogap Secures SEK 87 Million

Neogap Therapeutics has raised SEK 87 million in a financing round led by Sciety. The proceeds will fund the ongoing first-in-human clinical study evaluating personalized cell therapy in patients with advanced colorectal cancer. The trial focuses on safety and tolerability, aiming to establish data for upcoming development stages.

MedBridgeNZMedBridgeNZ
2026-02-09

Advanced CAR-T therapy shouldn't be out of reach.

Through Medical Tourism China, patients are accessing CD7-knockout & CLDN18.2 therapies at GoBroad Healthcare for ~85% less than US prices.

MedBridgeNZ is your concierge for this life-saving journey.

Read the report: zurl.co/PLUI3

David Ojciusojcius
2026-02-08

Cancers : les immunothérapies, des traitements révolutionnaires qui présentent des risques lemonde.fr/sciences/article/20

Tilda Moose, citizenMattMoose@mastodon.world
2026-02-06

#today I'm counting down the days til I start my last round of #immunotherapy for #bladder #cancer. Shots 25, 26 and 27 await. It's usually 3 over 3 weeks, every 6 months. I've been having this for several years now and it doesn't get any easier: outrageous #cystitis and prostate inflammation. Just hoping they'll find ever fewer recurrences that they'll want to laser away. Things could be worse.

In other news, I've nearly finished brooding over how to style my links page / blogroll.

Keep well

MedBridgeNZMedBridgeNZ
2026-02-05

From our in-depth interview on "Understanding Advanced Cancer Treatment Types: From Chemotherapy to CAR-T":

This clip focus on "Why Foreigners Are Flooding Chinese Hospitals"

Full article: zurl.co/WRCqA

Want to stay informed? Follow us for more short insights!

Scientific Frontlinesflorg
2026-02-04

Cell metabolism within specific "neighbourhoods" of non-small cell lung (NSCLC) acts as a critical determinant for patient response and resistance to

sflorg.com/2026/02/ongy0204260

Broermann AwardBroermannMedicalnnovationAward
2026-02-04

Today, on , we honor the groundbreaking work of BMIA 2025 laureates Prof. Carl June & Prof. Michel Sadelain, whose pioneering research in CAR-T cell therapy has revolutionized cancer treatment.

Today, on hashtag#WorldCancerDay 2026, we honor the groundbreaking work of BMIA 2025 laureates Prof. Carl June (University of Pennsylvania) & Prof. Michel Sadelain (Columbia University Department of Medicine), whose pioneering research in CAR-T cell therapy has revolutionized cancer treatment. By harnessing the power of a patient’s own immune system, their therapies have transformed outcomes for patients with previously untreatable blood cancers, turning life-threatening diagnoses into stories of hope and survival. Their work demonstrates the profound impact of innovation and translational research in medicine, showing how bold scientific discoveries can move from the lab to the clinic & save lives. Do you know an outstanding scientist whose work is shaping the future of medicine? Nominate them for the Broermann Medical Innovation Award 2026 by March 1! #cancer #cancercure #cancertreatment #cartcell #immunotherapyToday, on hashtag#WorldCancerDay 2026, we honor the groundbreaking work of BMIA 2025 laureates Prof. Carl June (University of Pennsylvania) & Prof. Michel Sadelain (Columbia University Department of Medicine), whose pioneering research in CAR-T cell therapy has revolutionized cancer treatment. By harnessing the power of a patient’s own immune system, their therapies have transformed outcomes for patients with previously untreatable blood cancers, turning life-threatening diagnoses into stories of hope and survival. Their work demonstrates the profound impact of innovation and translational research in medicine, showing how bold scientific discoveries can move from the lab to the clinic & save lives. Do you know an outstanding scientist whose work is shaping the future of medicine? Nominate them for the Broermann Medical Innovation Award 2026 by March 1! #cancer #cancercure #cancertreatment #cartcell #immunotherapyToday, on hashtag#WorldCancerDay 2026, we honor the groundbreaking work of BMIA 2025 laureates Prof. Carl June (University of Pennsylvania) & Prof. Michel Sadelain (Columbia University Department of Medicine), whose pioneering research in CAR-T cell therapy has revolutionized cancer treatment. By harnessing the power of a patient’s own immune system, their therapies have transformed outcomes for patients with previously untreatable blood cancers, turning life-threatening diagnoses into stories of hope and survival. Their work demonstrates the profound impact of innovation and translational research in medicine, showing how bold scientific discoveries can move from the lab to the clinic & save lives. Do you know an outstanding scientist whose work is shaping the future of medicine? Nominate them for the Broermann Medical Innovation Award 2026 by March 1! #cancer #cancercure #cancertreatment #cartcell #immunotherapyToday, on hashtag#WorldCancerDay 2026, we honor the groundbreaking work of BMIA 2025 laureates Prof. Carl June (University of Pennsylvania) & Prof. Michel Sadelain (Columbia University Department of Medicine), whose pioneering research in CAR-T cell therapy has revolutionized cancer treatment. By harnessing the power of a patient’s own immune system, their therapies have transformed outcomes for patients with previously untreatable blood cancers, turning life-threatening diagnoses into stories of hope and survival. Their work demonstrates the profound impact of innovation and translational research in medicine, showing how bold scientific discoveries can move from the lab to the clinic & save lives. Do you know an outstanding scientist whose work is shaping the future of medicine? Nominate them for the Broermann Medical Innovation Award 2026 by March 1! #cancer #cancercure #cancertreatment #cartcell #immunotherapy
MedBridgeNZMedBridgeNZ
2026-02-04

From our in-depth interview on "Understanding Advanced Cancer Treatment Types: From Chemotherapy to CAR-T":

This clip focus on "Who Gets to Live? The High Cost of Cancer Cures"

Full article: zurl.co/bh9tE

Want to stay informed? Follow us for more short insights!

MedBridgeNZMedBridgeNZ
2026-02-03

From our in-depth interview on "Understanding Advanced Cancer Treatment Types: From Chemotherapy to CAR-T":

This clip focus on "From Fire Hose to Sniper Rifle: The Cancer Revolution"

Full article: zurl.co/c4PoR

Want to stay informed? Follow us for more short insights!

MedBridgeNZMedBridgeNZ
2026-02-02

From our in-depth interview on "Understanding Advanced Cancer Treatment Types: From Chemotherapy to CAR-T":

This clip focus on "Cancer’s "Guided Missile" Explained"

Full article: zurl.co/QB5hY

Want to stay informed? Follow us for more short insights!

MedBridgeNZMedBridgeNZ
2026-02-01

From our in-depth interview on "Understanding Advanced Cancer Treatment Types: From Chemotherapy to CAR-T":

This clip focus on "Is This the End of Chemo?"

Full article: zurl.co/Zezok

Want to stay informed? Follow us for more short insights!

Scientific Frontlinesflorg
2026-01-31

An antibody-based successfully reduced volume and inflammation in murine models, demonstrating a novel ability to clear existing obstructions rather than simply preventing new growth.

sflorg.com/2026/01/imgy0131260

Client Info

Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst